PRKN and cancer: Likewise, the mRNA levels of PRKN exhibited a potential inhibitory effect on the activity of apoptosis (53%), the cell cycle (38%), and DNA damage (12%) pathways, but also demonstrated a potential activating effect on the activity of pathways like hormone AR (22%), hormone ER (22%), RTK (12%), and DNA damage (12%) in pan-cancer (Figure 3a).